Van Strum & Towne Inc. Amgen Inc Transaction History

Van Strum & Towne Inc.

$274 Million
Q1 2024

A detailed history of Van Strum & Towne Inc. transactions in Amgen Inc stock. As of the latest transaction made, Van Strum & Towne Inc. holds 32,973 shares of AMGN stock, worth $10.4 Million. This represents 3.43% of its overall portfolio holdings.

Number of Shares

32,973

Previous 33,263 0.87%

Holding current value

$10.4 Million

Previous $9.58 Million 2.15%

% of portfolio

3.43%

Previous 3.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $77,972 - $94,122	-290 Reduced 0.87%	32,973 $9.37 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $179,245 - $202,210	-701 Reduced 2.06%	33,263 $9.58 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $48,103 - $59,721	-220 Reduced 0.64%	33,964 $9.13 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $27,855 - $32,938	-130 Reduced 0.38%	34,184 $7.59 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $1,128 - $1,376	5 Added 0.01%	34,314 $8.3 Million

Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $57,257 - $72,752	250 Added 0.73%	34,309 $9.01 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $24,466 - $27,593	-109 Reduced 0.32%	34,059 $7.68 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $12,919 - $14,377	56 Added 0.16%	34,168 $8.31 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $126,080 - $139,477	575 Added 1.71%	34,112 $8.25 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $92,479 - $105,834	465 Added 1.41%	33,537 $7.55 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $9,552 - $11,191	-45 Reduced 0.14%	33,072 $7.03 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $193,871 - $215,086	-830 Reduced 2.44%	33,117 $8.07 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $118,721 - $138,351	-535 Reduced 1.55%	33,947 $8.45 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $190,414 - $226,749	-880 Reduced 2.49%	34,482 $7.93 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $139,616 - $155,265	595 Added 1.71%	35,362 $8.99 Million
Q2 2020 Jul 14, 2020	SELL	$197.81 - $242.74 $56,375 - $69,180	-285 Reduced 0.81%	34,767 $8.2 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $19,135 - $25,378	105 Added 0.3%	35,052 $7.11 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $43,518 - $55,936	-230 Reduced 0.65%	34,947 $8.43 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $564,116 - $675,928	3,240 Added 10.14%	35,177 $6.81 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $12,502 - $14,655	-75 Reduced 0.23%	31,937 $5.89 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Reduced 0.31%	32,012 $6.08 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $539,660 - $629,956	-3,025 Reduced 8.61%	32,112 $6.25 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $152,864 - $172,334	-825 Reduced 2.29%	35,137 $7.28 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $84,685 - $95,120	-510 Reduced 1.4%	35,962 $6.64 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $63,536 - $74,250	-375 Reduced 1.02%	36,472 $6.22 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $373,869 - $417,726	-2,215 Reduced 5.67%	36,847 $6.41 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $6.53 Million - $7.46 Million	39,062	39,062 $7.28 Million

Others Institutions Holding AMGN

# of Institutions

2,936

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Strum & Towne Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Strum & Towne Inc. with notifications on news.

Account

Van Strum & Towne Inc. Amgen Inc Transaction History